Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
PARTNER PROFILE FORM Date: Deadline: Call identifier: 21.03.2007 CONTACT INFORMATION Organisation Name Vilnius University Type of Research institute organization SME* Industry Contact person Sonata Jarmalaite University Other Telephone 370 5 2398259 Address Faculty of Natural Sci, Dept Botany & Genetics Ciurlionio 21, 03101 Vilnius, Lithuania Fax 370 5 2398204 Web site www.vu.lt E-mail Sonata.Jarmalaite@gf .vu.lt Department * Your enterprise is an SME if: -it has less than 250 employees -it has either an annual turnover not exceeding €50M, or an annual balance sheet total not over €43M -it is less than 25% owned by a non SME (unless these are financial investors, such as banks or venture capitalists EXPERTISE OFFERED Keywords specifying the expertise Description of the expertise Cancer genetics; cancer epigenetics; breast cancer; arthritis; molecular markers; circulating tumour DNA; genetic and epigenetic changes Our group has a long-standing expertise in the analysis of molecular and genetic mechanisms of human pathologies, including cancer and arthritis Cancer research. Our group is involved in studies on epigenetic and genetic biomarkers of cancer, for prognosis of disease outcome and identification of new targets for the treatment. Genetic and epigenetic changes in human cancer, including bladder, lung and gliomas have been studied. Currently, the study on molecular biomarkers of breast cancer for improved prognosis in early disease is initiated. Arthritis research. Our group has participated in the studies of molecular mechanisms of immune response in reactive and rheumatoid arthritis. Recently, the study of epigenetic changes in synovial tissues is initiated. Specific interests. We seek a partnership for collaborative research on molecular (epigenetic and genetic) biomarkers of breast cancer for early and non-invasive detection and prognosis of progression. Also, wee look for the partners for the analysis of molecular (genetic) changes in pathogenesis of arthritic diseases. Infrastructure. We have a wide range of techniques established in our labs including FISH and Comet analysis, chromosome aberration and micronucleus tests, DNA mutation analysis, DNA hypermethylation assay, gene expression analysis by TaqMan assay. The infrastructure for genetic research includes modern facility for Main researchers and expertise (name, surname, academic degree) tissue/cell culture, and molecular/cellular genetics are available in our labs. Sonata Jarmalaite, PhD Juozas R Lazutka, Prof. Relevant publications: Norppa H…Lazutka JR et al. Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat Res. 2006 Aug 30; 600(1-2):37-45. Epub 2006 Jul 11. Review. Boffetta P…Lazutka JR. et al., Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe.Am J Epidemiol. 2007 Jan 1;165(1):36-43. Jarmalaite S., Kannio A., Anttila S., Lazutka J.R. and HusgafvelPursiainen K. Aberrant p16 promoter methylation in smokers and former smokers with non-small cell lung cancer. Int J Cancer, 2003, 106, 6: 913-18. Wikman H, Nymark P, Väyrynen A, Jarmalaite S, Kallioniemi A, Salmenkivi K, Vainio-Siukola K, Husgafvel-Pursiainen K, Knuutila S, Wolf M, Anttila S. CDK4 is a probable target gene in a novel amplicon on 12q13.3q14.1 in lung cancer. Genes, Chromosomes and Cancer, 2005, 42:193-199. Butrimiene I., Jarmalaite S., Ranceva J., Venalis A., Jasiuleviciute L. and Zvirbliene A. Different cytokine profiles in patients with chronic and acute reactive arthritis. Rheumatology , 2004, 43(10):1300-4. Experience in international cooperation and partnership (SMEs, universities, research institutes) International projects (last 5 years - Title of project, source of funds, duration) Please, indicate if you were/are coordinator, partner or subcontractor EXPECTATIONS Target consortium Please, indicate the topic title from the work programme ENLINO Master Programme – Network in Environmental Sciences, funded by Norwegian Centre for International Cooperation in Higher Education (SIU), 2003-2005, coordinator Long standing collaboration with Finnish Institute of Occupational Health Cytogenetic Biomarkers and Human Cancer Risk, FP project No. QLK4-CT-2000-00628, 2002-2004, partner HEALTH-2007-1.2-6 High throughput molecular diagnostics in individual patients for genetic diseases with heterogenous clinical presentation. HEALTH-2007-2.1.2-5 Multidisciplinary fundamental genomics and molecular biology approaches to study basic biological processes relevant to health and disease HEALTH-2007-2.4.1-10 Role of inflammation in tumour initiation and progression HEALTH-2007-2.4.5-12 Early processes in the pathogenesis of chronic inflammatory diseases